Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial
Abstract Background Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of some chemotherapy regimens. Lithium has been suggested for CIPN in some animal studies. We aimed to study lithium’s preventive effect on CIPN in breast cancer patients treated with taxanes and platinu...
Guardado en:
Autores principales: | S. Najafi, Z. Heidarali, M. Rajabi, Z. Omidi, F. Zayeri, M. Salehi, S. Haghighat |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/69e2cadfe47f45b0b317ff23a30c1f8e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
por: Nicolas Kerckhove, et al.
Publicado: (2021) -
Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy
por: Sandy Eldridge, et al.
Publicado: (2021) -
EFFICACY AND SAFETY OF DULOXETINE IN THE TREATMENT OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: I Putu Eka Widyadharma, et al.
Publicado: (2021) -
An adolescent rat model of vincristine-induced peripheral neuropathy
por: Ai-Ling Li, et al.
Publicado: (2021) -
Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes
por: Matthew R. Trendowski, et al.
Publicado: (2021)